Prepare for your visit
Danielle R Waldrop
Obstetrics & Gynecology · Greenbelt, MD · NPI 1164682126
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$428.26
in general payments reported to CMS, 2019-2025 · $126 in 2025
The $126 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Who reported paying
General payments only, top 6 by amount.
- Astellas Pharma US INC $135.91
- Optumhealth Care Solutions, LLC $97.85
- Organon LLC $92.77
- Mylan Pharmaceuticals INC. $61.80
- Shield Therapeutics INC $25.76
- Avion Pharmaceuticals $14.17
Drugs and devices associated with these payments
Vivify Health Care Team Portal 001 Eitan Medical Nexplanon Veozah Accrufer
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Danielle Waldrop listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/823403/danielle-r-waldrop